The Motley Fool··Matthew BenjaminTrump's Psychedelic Fast-Track Order Opens New Frontier for FDA Approvals
Trump executive order accelerates psychedelic drug approvals from 6-10 months to 1-2 months, allocates $50M for research, benefiting biotech companies.
DFTXCMPStreatment-resistant depressionmental health